Meeting
2012 Gastrointestinal Cancers Symposium
Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy.
Authors
Xuezhong Yang
Georgetown University Hospital Lombardi Cancer Center, Washington, DC
Xuezhong Yang , Christina Sing-Ying Wu , Jimmy J. Hwang , Benjamin Weinberg , Michael J. Pishvaian , Aiwu Ruth He , John Marshall
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 333)
DOI
10.1200/jco.2012.30.4_suppl.333
Abstract #
333
Poster Bd #
E17
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Patterns of surgery and adjuvant therapy in pancreatic carcinoid tumor: An NCDB analysis.
First Author: Connor Lanoue
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A randomized, multi-center phase III trial of adjuvant chemotherapy with gemcitabine and capecitabine (GemCap) compared to capecitabine (Cap) alone in curatively resected biliary tract cancer (BilGemCap Study): KCSG HB20-14.
First Author: Joon Oh Park
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.
First Author: Michele Reni
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Adjuvant gemcitabine (GEM) versus gemcitabine plus capecitabine (GEMCAP) in resected pancreatic adenocarcinoma: A retrospective analysis.
First Author: Sora Kang